130 related articles for article (PubMed ID: 6249625)
1. Effects of prazosin on the cAMP system in the spontaneously hypertensive rat (SHR) aorta.
D'Armiento M; Lacerna F; Lauro R; Modesti A; Verna R; Ceccarelli G
Eur J Pharmacol; 1980 Jul; 65(2-3):243-7. PubMed ID: 6249625
[TBL] [Abstract][Full Text] [Related]
2. Effects of prazosin on cyclic nucleotide content and blood pressure of the spontaneously hypertensive rat.
Sands H; Jorgensen R
Biochem Pharmacol; 1979 Mar; 28(5):685-7. PubMed ID: 220983
[No Abstract] [Full Text] [Related]
3. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
6. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats.
Saha S; Li Y; Anand-Srivastava MB
Can J Physiol Pharmacol; 2008 Apr; 86(4):190-8. PubMed ID: 18418428
[TBL] [Abstract][Full Text] [Related]
7. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the adenylate cyclase-cAMP-phosphodiesterase system in the locus coeruleus during the development of spontaneous hypertension of the rat.
Bahner U; Schmid G; Palkovits M; Geiger H; Heidland A
J Neurosci Res; 1987; 18(3):473-8. PubMed ID: 2830411
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase-cyclic AMP-phosphodiesterase system in microdissected brain areas of normotensive and spontaneously hypertensive rats.
Bahner U; Palkovits M; Geiger H; Schmid G; Heidland A
J Chem Neuroanat; 1989; 2(1):45-55. PubMed ID: 2551340
[TBL] [Abstract][Full Text] [Related]
10. A comparison of cyclic AMP signaling system in rat aortic myocytes in primary culture and aorta.
Schoeffter P; Lugnier C; Travo C; Stoclet JC
Lab Invest; 1989 Aug; 61(2):177-82. PubMed ID: 2474090
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine monophosphate and hypertension in rats.
Amer MS
Science; 1973 Feb; 179(4075):807-9. PubMed ID: 4346170
[TBL] [Abstract][Full Text] [Related]
12. Changes in cyclic nucleotide metabolism in aorta and heart of neurogenically hypertensive rats: possible trigger mechanism of hypertension.
Amer MS; Doba N; Reis DJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2135-9. PubMed ID: 237270
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
14. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
15. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
16. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.
Pinsky D; Oz M; Liao H; Morris S; Brett J; Sciacca R; Karakurum M; Van Lookeren Campagne M; Platt J; Nowygrod R
J Clin Invest; 1993 Dec; 92(6):2994-3002. PubMed ID: 8254053
[TBL] [Abstract][Full Text] [Related]
17. Variations in the levels of cyclic adenosine 3':5'-monophosphate and in the activities of adenylate cyclase and cyclic adenosine 3':5'-monophosphate phosphodiesterase during aerobic morphogenesis of Mucor rouxii.
Cantore ML; Galvagno MA; Passeron S
Arch Biochem Biophys; 1980 Feb; 199(2):312-20. PubMed ID: 6244775
[No Abstract] [Full Text] [Related]
18. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP metabolism in the cardiac tissue of the spontaneously hypertensive rat.
Ramanathan S; Shibata S; Tasaki TK; Ichord RN
Biochem Pharmacol; 1976 Jan; 25(2):223-5. PubMed ID: 177025
[No Abstract] [Full Text] [Related]
20. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
Gabbay RA; Lardy HA
FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
